Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2247 ARTÍCULOS , VIENDO DEL 1021 AL 1035

Alzheimer Disease: Treatment of Cognitive and Functional Symptoms

Jaqua EE, Tran MN, Hanna M.

Am Fam Physician. 2024 Sep;110(3):281-293.

Atomically dispersed single-atom catalysts (SACs) and enzymes (SAzymes): synthesis and application in Alzheimer's disease detection

Goel H, Rana I, Jain K, Ranjan KR, Mishra V.

J Mater Chem B. 2024 Oct 23;12(41):10466-10489. doi: 10.1039/d4tb01293c.

Integrating amyloid and tau imaging with proteomics and genomics in Alzheimer's disease

Vilkaite G, Vogel J, Mattsson-Carlgren N.

Cell Rep Med. 2024 Sep 17;5(9):101735. doi: 10.1016/j.xcrm.2024.101735.

AI-driven innovations in Alzheimer's disease: Integrating early diagnosis, personalized treatment, and prognostic modelling

Kale M, Wankhede N, Pawar R, Ballal S, Kumawat R, Goswami M, Khalid M, Taksande B, Upaganlawar A, Umekar M, Kopalli SR, Koppula S.

Ageing Res Rev. 2024 Nov;101:102497. doi: 10.1016/j.arr.2024.102497. Epub 2024 Sep 16.

Measuring clinically relevant change in apathy symptoms in ADMET and ADMET 2

Tumati S, Herrmann N, Perin J, Rosenberg PB, Lerner AJ, Mintzer J, Padala PR, Brawman-Mintzer O, van Dyck CH, Porsteinsson AP, Craft S, Levey A, Shade D, Lanctôt KL.

Int Psychogeriatr. 2024 Dec;36(12):1232-1244. doi: 10.1017/S1041610224000711. Epub 2024 Sep 19.

Brain volume change following anti-amyloid β immunotherapy for Alzheimer's disease: amyloid-removal-related pseudo-atrophy

Belder CRS, Boche D, Nicoll JAR, Jaunmuktane Z, Zetterberg H, Schott JM, Barkhof F, Fox NC.

Lancet Neurol. 2024 Oct;23(10):1025-1034. doi: 10.1016/S1474-4422(24)00335-1.

Prescription of Nonpharmacologic Interventions in Memory Clinics: Data from the Clinical Pathway for Alzheimer's Disease in China (CPAD) Study

Cai X, Zhang Y, Shi C, Wong GHY, Luo H, Wang H.

J Am Med Dir Assoc. 2024 Dec;25(12):105273. doi: 10.1016/j.jamda.2024.105273. Epub 2024 Sep 19.

Unveiling the theranostic potential of SPIONs in Alzheimer's disease management

Aminyavari S, Afshari AR, Ahmadi SS, Kesharwani P, Sanati M, Sahebkar A.

J Psychiatr Res. 2024 Nov;179:244-256. doi: 10.1016/j.jpsychires.2024.09.022. Epub 2024 Sep 20.

Amyloid related imaging abnormalities in the emergency setting

Czerminski J, Khatri S, Rao B.

Emerg Radiol. 2024 Dec;31(6):937-941. doi: 10.1007/s10140-024-02286-2. Epub 2024 Sep 27.

Digital Health Technologies for Alzheimer's Disease and Related Dementias: Initial Results from a Landscape Analysis and Community Collaborative Effort

Lott SA, Streel E, Bachman SL, Bode K, Dyer J, Fitzer-Attas C, Goldsack JC, Hake A, Jannati A, Fuertes RS, Fromy P.

J Prev Alzheimers Dis. 2024;11(5):1480-1489. doi: 10.14283/jpad.2024.103.

Alzheimer Disease Is a Specific Disorder Defined by Neuropathology Detectable During Life

Jagust WJ.

Neurology. 2024 Nov 12;103(9):e209995. doi: 10.1212/WNL.0000000000209995. Epub 2024 Oct 1.

Public perceptions related to healthcare preparedness to anti-amyloid therapies for Alzheimer's Disease in Japan

Sato K, Niimi Y, Ihara R, Iwata A, Suzuki K, Nemoto K, Arai T, Higashi S, Igarashi A, Kasuga K, Awata S, Iwatsubo T.

Alzheimers Res Ther. 2024 Oct 3;16(1):205. doi: 10.1186/s13195-024-01568-8.

Hyperspectral retinal imaging in Alzheimer's disease and age-related macular degeneration: a review

Du X, Park J, Zhao R, Smith RT, Koronyo Y, Koronyo-Hamaoui M, Gao L.

Acta Neuropathol Commun. 2024 Oct 3;12(1):157. doi: 10.1186/s40478-024-01868-y.

Functional Magnetic Resonance Imaging in Alzheimer's Disease Drug Trials: A Mini-Review

Alghamdi M, Braidy N.

J Alzheimers Dis. 2024;101(s1):S567-S578. doi: 10.3233/JAD-231276.

PET/CT/MRI in Clinical Trials of Alzheimer's Disease

Høilund-Carlsen PF, Alavi A, Barrio JR.

J Alzheimers Dis. 2024;101(s1):S579-S601. doi: 10.3233/JAD-240206.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias